CRISPR-based platforms for detecting tumor-associated genetic materials in clinical samples.
Sign Up to like & getrecommendations! Published in 2025 at "Bioanalysis"
DOI: 10.1080/17576180.2025.2571023
Abstract: Tumor-associated genetic markers are useful for early cancer screening, diagnosis, and treatment monitoring. However, traditional detection methods are complex in operation procedures, time-consuming, and the equipment costs are expensive. CRISPR/Cas systems are becoming emerging detection… read more here.
Keywords: detection; detecting tumor; associated genetic; tumor associated ... See more keywords